{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:22:50Z","timestamp":1794072170118,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01662-x","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:05:13Z","timestamp":1768817113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Additive value of whole abdomen FDG PET\/MRI to standard whole body PET\/CT for detection of peritoneal recurrence of ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Muhammet Halil","family":"Baltacioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Soydal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Araz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digdem","family":"Kuru Oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuriye Ozlem","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl Ayse","family":"Erden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilla Halil","family":"Elhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"1662_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1662_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","volume":"41","author":"PM Webb","year":"2017","unstructured":"Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3\u201314.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1662_CR3","doi-asserted-by":"crossref","unstructured":"Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70:209\u2013262.","DOI":"10.1016\/S0020-7292(00)90001-8"},{"key":"1662_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00404-020-05522-5","volume":"301","author":"M Miku\u0161","year":"2020","unstructured":"Miku\u0161 M, Benco N, Matak L, Planini\u0107 P, \u0106ori\u0107 M, Lovri\u0107 H, et al. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center. Arch Gynecol Obstet. 2020;301:1227\u201333.","journal-title":"Arch Gynecol Obstet"},{"key":"1662_CR5","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384:1376\u201388.","journal-title":"Lancet"},{"key":"1662_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bpobgyn.2016.10.009","volume":"41","author":"J Sehouli","year":"2017","unstructured":"Sehouli J, Grabowski JP. Surgery for recurrent ovarian cancer: options and limits. Best Pract Res Clin Obstet Gynaecol. 2017;41:88\u201395.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1662_CR7","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","volume":"385","author":"P Harter","year":"2021","unstructured":"Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, et al. Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med. 2021;385:2123\u201331.","journal-title":"N Engl J Med"},{"key":"1662_CR8","first-page":"198","volume":"3","author":"VM Vargas-Hern\u00e1ndez","year":"2014","unstructured":"Vargas-Hern\u00e1ndez VM, Moreno-Eutimio MA, Acosta-Altamirano G, Vargas-Aguilar VM. Management of recurrent epithelial ovarian cancer. Gland Surg. 2014;3:198\u2013202.","journal-title":"Gland Surg"},{"key":"1662_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/rct.0b013e31803e8c45","volume":"31","author":"CK Kim","year":"2007","unstructured":"Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET\/CT. J Comput Assist Tomogr. 2007;31:868\u201375.","journal-title":"J Comput Assist Tomogr"},{"key":"1662_CR10","doi-asserted-by":"crossref","unstructured":"Wang X, Yang L, Wang Y. Meta-analysis of the diagnostic value of (18)F-FDG PET\/CT in the recurrence of epithelial ovarian cancer. Front Oncol 2022;12","DOI":"10.3389\/fonc.2022.1003465"},{"key":"1662_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.mric.2017.03.012","volume":"25","author":"MA Ohliger","year":"2017","unstructured":"Ohliger MA, Hope TA, Chapman JS, Chen LM, Behr SC, Poder L. PET\/MR Imaging in Gynecologic Oncology. Magn Reson Imaging Clin N Am. 2017;25:667\u201384.","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"1662_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/RLU.0000000000000768","volume":"40","author":"S Schmidt","year":"2015","unstructured":"Schmidt S, Meuli RA, Achtari C, Prior JO. Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET\/CT. Clin Nucl Med. 2015;40:371\u20137.","journal-title":"Clin Nucl Med"},{"key":"1662_CR13","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.ejrad.2010.07.013","volume":"80","author":"P De Iaco","year":"2011","unstructured":"De Iaco P, Musto A, Orazi L, Zamagni C, Rosati M, Allegri V, et al. FDG-PET\/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. Eur J Radiol. 2011;80:e98-103.","journal-title":"Eur J Radiol"},{"key":"1662_CR14","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1007\/s00259-021-05450-9","volume":"48","author":"RC Delgado Bolton","year":"2021","unstructured":"Delgado Bolton RC, Aide N, Colletti PM, Ferrero A, Paez D, Skanjeti A, et al. EANM guideline on the role of 2-[18F]FDG PET\/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging. 2021;48:3286\u2013302.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1662_CR15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00330-012-2397-2","volume":"22","author":"M Soussan","year":"2012","unstructured":"Soussan M, Des Guetz G, Barrau V, Aflalo-Hazan V, Pop G, Mehanna Z, et al. Comparison of FDG-PET\/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol. 2012;22:1479\u201387.","journal-title":"Eur Radiol"},{"key":"1662_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40644-021-00399-2","volume":"21","author":"B J\u00f3nsd\u00f3ttir","year":"2021","unstructured":"J\u00f3nsd\u00f3ttir B, Ripoll MA, Bergman A, Silins I, Poromaa IS, Ahlstr\u00f6m H, et al. Validation of 18F-FDG PET\/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study. Cancer Imaging. 2021;21:34.","journal-title":"Cancer Imaging"},{"key":"1662_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00259-014-2902-8","volume":"42","author":"K Beiderwellen","year":"2015","unstructured":"Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P, et al. [(18)F]FDG PET\/MRI vs. PET\/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging. 2015;42:56\u201365.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1662_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172553","volume":"12","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, et al. Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET\/MRI compared to 18F-FDG PET\/CT and CT. PLoS ONE. 2017;12: e0172553.","journal-title":"PLoS ONE"},{"key":"1662_CR19","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s00330-015-3657-8","volume":"25","author":"MA Queiroz","year":"2015","unstructured":"Queiroz MA, Kubik-Huch RA, Hauser N, Freiwald-Chilla B, von Schulthess G, Froehlich JM, et al. PET\/MRI and PET\/CT in advanced gynaecological tumours: initial experience and comparison. Eur Radiol. 2015;25:2222\u201330.","journal-title":"Eur Radiol"},{"key":"1662_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00259-006-0306-0","volume":"34","author":"G Mangili","year":"2007","unstructured":"Mangili G, Picchio M, Sironi S, Vigan\u00f2 R, Rabaiotti E, Bornaghi D, et al. Integrated PET\/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging. 2007;34:658\u201366.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1662_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ygyno.2006.03.004","volume":"103","author":"B Simcock","year":"2006","unstructured":"Simcock B, Neesham D, Quinn M, Drummond E, Milner A, Hicks RJ. The impact of PET\/CT in the management of recurrent ovarian cancer. Gynecol Oncol. 2006;103:271\u20136.","journal-title":"Gynecol Oncol"},{"key":"1662_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43055-019-0002-2","volume":"50","author":"MAG ElHariri","year":"2019","unstructured":"ElHariri MAG, Harira M, Riad MM. The usefulness of PET-CT in the evaluation of suspected recurrent ovarian carcinoma. Egypt J Radiol Nucl Med. 2019;50:2.","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"7","key":"1662_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ejso.2005.02.029","volume":"31","author":"C Nanni","year":"2005","unstructured":"Nanni C, Rubello D, Farsad M, De Iaco P, Sansovini M, et al. (18)F-FDG PET\/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. Eur J Surg Oncol. 2005;31(7):792\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"3\u20134","key":"1662_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000159266","volume":"75","author":"A Fagotti","year":"2008","unstructured":"Fagotti A, Fanfani F, Rossitto C, Lorusso D, De Gaetano AM, et al. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy. Oncology. 2008;75(3\u20134):152\u20138.","journal-title":"Oncology"},{"issue":"Suppl 1","key":"1662_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ijgc-00009577-200602001-00016","volume":"16","author":"M Murakami","year":"2006","unstructured":"Murakami M, Miyamoto T, Iida T, Tsukada H, Watanabe M, et al. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer. 2006;16(Suppl 1):99\u2013107.","journal-title":"Int J Gynecol Cancer"},{"key":"1662_CR26","doi-asserted-by":"crossref","unstructured":"Mayerhoefer M, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, et al. PET\/MRI versus PET\/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl Med Mol Imaging. 2020;47:5160.","DOI":"10.1007\/s00259-019-04452-y"},{"key":"1662_CR27","doi-asserted-by":"crossref","unstructured":"Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, et al. PET\/MRI: Where might it replace PET\/CT?. J Magn Reson Imaging. 2017;46:124762.","DOI":"10.1002\/jmri.25872"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01662-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:09:19Z","timestamp":1769090959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01662-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1662"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01662-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}